<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03145168</url>
  </required_header>
  <id_info>
    <org_study_id>ILBS-Cirrhosis-08</org_study_id>
    <nct_id>NCT03145168</nct_id>
  </id_info>
  <brief_title>High Versus Low Target Mean Arterial Pressure in Septic Shock in Critically Ill Cirrhotics</brief_title>
  <official_title>High Versus Low Target Mean Arterial Pressure in Septic Shock in Critically Ill Cirrhotics -A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Liver and Biliary Sciences, India</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute of Liver and Biliary Sciences, India</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study Design:&#xD;
&#xD;
        -  A randomized controlled study.&#xD;
&#xD;
        -  The study will be conducted on patients admitted to Department of Hepatology from April&#xD;
           2017 to October 2017 at ILBS, New Delhi&#xD;
&#xD;
        -  Study group will comprise of patients critically ill cirrhotics with septic shock&#xD;
&#xD;
      All included patients would be randomised to low target MAP group (60-65mm Hg) or high target&#xD;
      group (80-85 mm of Hg). Patients older than 18 years of age will be enrolled if they have&#xD;
      septic shock that is refractory to fluid resuscitation and if they required vasopressors&#xD;
      (norepinephrine or epinephrine or terlipressin) at a minimum infusion rate of 0.1 μg per&#xD;
      kilogram per minute. Standard criteria will be considered to define refractoriness to fluids.&#xD;
      The target MAP would be maintained for a max. of 5 days or until recovery or shock and or&#xD;
      AKI. In the high-target group, a reduction in vasopressor doses to maintain a mean arterial&#xD;
      pressure of 65 to 70 mm Hg will be done in case of any of the prespecified serious adverse&#xD;
      events that could potentially be related to an increased rate of vasopressor infusion&#xD;
      occurred. These events could be: clinically relevant bleeding (i.e., transfusion requirements&#xD;
      of at least 2 units of packed red cells), myocardial infarction (defined as typical&#xD;
      electrocardiographic changes, with a concomitant increase in troponin, and segmental&#xD;
      echocardiographic hypokinesia or akinesia, with the infarction confirmed, when possible, by&#xD;
      means of coronary angiography), major ventricular arrhythmia, poorly tolerated&#xD;
      supraventricular arrhythmia, mesenteric ischemia, and distal-limb ischemia.&#xD;
&#xD;
      • Septic shock would be defined as clinical construct of sepsis with persisting hypotension&#xD;
      requiring vasopressors to maintain MAP&gt;=65 mm of Hg and having a serum lactate &gt;2 mmol/L&#xD;
      despite adequate volume resuscitation&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">July 31, 2018</start_date>
  <completion_date type="Anticipated">July 25, 2019</completion_date>
  <primary_completion_date type="Anticipated">July 25, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival in both groups</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of intradialytic hypotension in patients undergoing Renal Replacement Therapy</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Intensive Care Unit /Hospital stay</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reversal of shock in both groups</measure>
    <time_frame>Day 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute Kidney Injury in both groups.</measure>
    <time_frame>Day 5</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2</enrollment>
  <condition>Cirrhosis</condition>
  <arm_group>
    <arm_group_label>High Target Mean Arterial Pressure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Low target Mean Arterial Pressure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Target Mean Arterial Pressure</intervention_name>
    <description>High target group (80-85 mm of Hg).</description>
    <arm_group_label>High Target Mean Arterial Pressure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low Target Mean Arterial Pressure</intervention_name>
    <description>Low target MAP group (60-65mm Hg).</description>
    <arm_group_label>Low target Mean Arterial Pressure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Critically ill cirrhotics with septic shock&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with age less than 18 years&#xD;
&#xD;
          -  Severe known cardiopulmonary disease (structural or valvular heart disease, coronary&#xD;
             artery disease, COPD)&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Chronic kidney disease on hemodialysis&#xD;
&#xD;
          -  Extremely moribund patients with an expected life expectancy of less than 24 hours&#xD;
&#xD;
          -  Failure to give informed consent from family members.&#xD;
&#xD;
          -  Hemodynamic instability requiring very high dose of vasopressors&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dr Rakhi Maiwall, MD, DM</last_name>
    <phone>01146300000</phone>
    <email>rakhi_2011@yahoo.co.in</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institute of Liver and Biliary Sciences</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110070</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>April 10, 2017</study_first_submitted>
  <study_first_submitted_qc>May 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 9, 2017</study_first_posted>
  <last_update_submitted>July 26, 2018</last_update_submitted>
  <last_update_submitted_qc>July 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

